HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Laugen Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

7/2005Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian Laugen Research Topics

Disease

2Lymphoma (Lymphomas)
07/2005 - 04/2004
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2005
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2004

Drug/Important Bio-Agent (IBA)

1CT-32228IBA
07/2005
1CaspasesIBA
07/2005
1Monoclonal AntibodiesIBA
07/2005
1ThymidineIBA
07/2005
12-acylglycerophosphate acyltransferaseIBA
07/2005
1AntibodiesIBA
04/2004
1CD20 AntigensIBA
04/2004
1Rituximab (Mabthera)FDA Link
04/2004

Therapy/Procedure

1Therapeutics
07/2005
1Immunotherapy
04/2004